PDCD1 and melanoma: On the other hand, immune checkpoint inhibitors including PD‐1/PD‐L1 inhibitors and cytotoxic T‐lymphocyte antigen 4 (CTLA‐4) inhibitors changed the treatment landscape of advanced melanoma.